At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells: Phase II Double-Blind Placebo-Controlled Randomized Clinical Trials.
In Brief
A Phase 2 clinical trial evaluating allogenic adipose stem cell injection, fibrin glue/normal saline injection, and 1 other intervention for Rotator Cuff Tear. Completed, enrolled 24 participants across 1 site.
Detailed Summary
Main purpose of this study is to evaluate efficacy of allogenic adipose-derived mesenchymal stem cells in treatment of tendon injury. ALLO-ASC will be administrated to the patients with supraspinatus partial thickness tear by ultrasonographic guided injection.
Study Details
Timeline
Interventions
Intervention will be done with stem cell injection, 0.5cc (Total: 10 million cells), fibrin glue injection 0.5cc and range of motion exercise.
Total 1cc of fibin glue and normal saline mixture injection and range of motion exercise
Total 1cc of normal saline injection and range of motion exercise